Could circRNA be a new biomarker for pre-eclampsia?

Area of Science:

• Obstetrics and Gynecology
• Molecular Biology
• Genetics

Background:

• Pre-eclampsia is a major cause of maternal and fetal mortality and morbidity.
• Current risk factors identify only 30% of susceptible pregnancies.
• Early detection biomarkers are crucial due to pre-eclampsia's heterogeneous nature.

Purpose of the Study:

• To review current evidence on circular RNAs (circRNAs) in pre-eclampsia.
• To explore the potential of circRNAs as biomarkers for pre-eclampsia.
• To assess the mechanisms underlying circRNA involvement in pre-eclampsia.

Main Methods:

• Literature review of recent studies on circRNAs and pre-eclampsia.
• Analysis of circRNA characteristics (abundance, specificity, organization).
• Assessment of proposed molecular mechanisms.

Main Results:

• Circular RNAs (circRNAs) exhibit unique properties making them suitable biomarkers.
• Emerging evidence suggests circRNAs play a role in pre-eclampsia pathogenesis.
• Further research is needed to validate circRNAs as reliable pre-eclampsia biomarkers.

Conclusions:

• Circular RNAs (circRNAs) represent a promising area for pre-eclampsia biomarker discovery.
• Understanding circRNA mechanisms could lead to improved early detection strategies.
• Increased awareness among clinicians regarding circRNAs is warranted.